跳至主要内容
临床试验/NCT01876355
NCT01876355尚未招募3 期

The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients CATAPRES (Confusion and Alpha-Two Agonist Prescription Randomised Efficacy Study)

Deventer Ziekenhuis1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2024年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
115
试验地点
1
主要终点
CAM-ICU (Confusion Assessment Method for the Intesive Care Unit)

研究概览

简要总结

Rationale: Delirium is highly prevalent in the ICU. GABA-ergic anaesthetics may provoke delirium. Alpha-2-adrenergic agonists may lead to a reduction of the total amount of GABA-ergic anaesthetics and reduction of delirium. There are no large studies proving that this therapy is effective and safe.

Objective: The objective of this study is to compare the effect of clonidine with placebo on the occurrence and duration of delirium in mechanically ventilated ICU patients.

Study design: Prospective randomised double-blind placebo controlled intervention study in 115 patients.

Study population: All patients >18 years old, intubated mechanically ventilated and sedated at inclusion.

Intervention: Clonidine infusion of 0,25 mcg/kg/h added to the standard sedation regimen. Comparison: NaCl 0,9 % infusion as placebo.

Main study parameters/endpoints: The main study parameter is the total number of awake and delirium-free observation periods the first 7 days after randomisation. An observation period is a nursing shift of 8 hours.

详细描述

Rationale: Delirium is highly prevalent in the ICU. It may cause significant morbidity and mortality. One of the factors that may provoke a delirium is the use of GABA-ergic anaesthetics. Recent studies have shown that sedation with alpha-2-adrenergic agonists may lead to a reduction of the total amount of GABA-ergic anaesthetics and reduction of delirium. In clinical practice the alpha-2-adrenergic agent clonidine is used as an add-on sedative in mechanically ventilated patients who suffer from delirium, but there are no large studies proving that this therapy is effective and safe.

Objective: The objective of this study is to compare the effect of clonidine with placebo on the occurrence and duration of delirium in mechanically ventilated ICU patients.

Study design: Prospective randomised double-blind placebo controlled intervention study in 115 patients.

Study population: All patients >18 years old, intubated mechanically ventilated and sedated at inclusion.

Intervention: Clonidine infusion of 0,25 mcg/kg/h added to the standard sedation regimen. Comparison: NaCl 0,9 % infusion as placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Intubated and mechanically ventilated, at the start of the study medication.
  • Age > 18 years

排除标准

  • Severe neurotrauma/CVA
  • Severe dementia
  • Inability to speak Dutch or English
  • The use of clonidine during the 96 hours before the start of the study.
  • Bradycardia (<50/min)
  • Severe hypotension (MAP < 65 after volume resuscitation and two vasopressors)
  • Pregnancy
  • Known clonidine intolerance
  • Liver cirrhosis (Child-Pugh Class C)
  • Recent and acute myocardial infarction
  • Severe heart failure (LVEF<30%)
  • Second or third degree AV block
  • Renal insufficiency requiring intermittent haemodialysis (CVVH is permitted)
  • Expected transfer to another hospital

研究组 & 干预措施

Sodium chloride

Placebo Comparator

干预措施: SodiumChloride (Drug)

Clonidine

Experimental

干预措施: Clonidine (Drug)

结局指标

主要结局

CAM-ICU (Confusion Assessment Method for the Intesive Care Unit)

时间窗: 7 days

The total amount of delirium-free periods during 7 days after randomisation and start of the study medication. An observation period is a period of 8 hours, coinciding with one nursing shift. A delirium-free period is a shift in which the delirium score is negative.

次要结局

  • Opiate use(7 days)
  • Ventilation free days(7 days)
  • Signs of agitation(7 days)
  • Sedation free days(7 days)
  • Sedative use(7 days)
  • Anti-psychotic use(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marieke Zeeman

Principal Investigator

Deventer Ziekenhuis

研究点 (1)

Loading locations...

相似试验

The Effect of Clonidine-enhanced Sedation on... | 临床试验